Prodomini, Sara
 Distribuzione geografica
Continente #
NA - Nord America 137
EU - Europa 136
AS - Asia 114
Totale 387
Nazione #
US - Stati Uniti d'America 136
CN - Cina 60
IT - Italia 48
GB - Regno Unito 22
SE - Svezia 17
SG - Singapore 16
IE - Irlanda 14
RU - Federazione Russa 11
VN - Vietnam 11
FR - Francia 10
KR - Corea 8
IN - India 7
BE - Belgio 5
DE - Germania 5
TW - Taiwan 5
ID - Indonesia 3
PH - Filippine 2
TR - Turchia 2
UA - Ucraina 2
CA - Canada 1
LV - Lettonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 387
Città #
Chandler 28
Ann Arbor 20
Southend 16
Dublin 14
Singapore 13
Verona 13
Beijing 12
Ashburn 10
Dearborn 9
Dong Ket 9
Jacksonville 8
Bengaluru 5
Brussels 5
Jinan 5
New York 5
Bussolengo 4
Hebei 4
Lawrence 4
Nanjing 4
Princeton 4
Redmond 4
Wilmington 4
Zhengzhou 4
Buk-gu 3
Hearne 3
Jakarta 3
Shenyang 3
Yongin-si 3
Boardman 2
Brescia 2
Changsha 2
College Station 2
Ferrara 2
Frankfurt am Main 2
Haikou 2
Houston 2
Seoul 2
Tainan City 2
Taizhou 2
Tarlac City 2
Tianjin 2
Turin 2
Andover 1
Bratislava 1
Camerino 1
Clearwater 1
Hangzhou 1
Hefei 1
Jiaxing 1
Kemerovo 1
Konya 1
Kunming 1
Legnago 1
Lucknow 1
Mumbai 1
Nanchang 1
Naples 1
Napoli 1
Nashua 1
Ningbo 1
Norwalk 1
Oklahoma City 1
Provo 1
Redwood City 1
Riga 1
Riva 1
San Giovanni Lupatoto 1
Santa Clara 1
Taipei 1
Taiyuan 1
Tallahassee 1
Vancouver 1
Totale 277
Nome #
Onconase cytotoxicity in melanoma cancer cells: promising results to be enforced by oligomerizing the protein 132
Antitumor effect of Onconase in A375 melanoma cell line. A proteomic analysis. 114
Human angiogenin dimerization and S28N pathogenic mutation. 80
Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells 69
Totale 395
Categoria #
all - tutte 1.156
article - articoli 239
book - libri 0
conference - conferenze 917
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202038 0 0 0 0 0 0 10 2 3 11 7 5
2020/202165 6 9 5 7 7 4 1 1 7 1 4 13
2021/202241 5 16 1 0 1 3 0 2 2 0 3 8
2022/202386 4 13 8 13 9 21 0 7 9 0 1 1
2023/202459 4 2 2 7 1 8 1 11 0 6 9 8
2024/202552 11 8 3 21 8 1 0 0 0 0 0 0
Totale 395